JPS5862116A - Multiplication promoting substance for hepatic cell - Google Patents

Multiplication promoting substance for hepatic cell

Info

Publication number
JPS5862116A
JPS5862116A JP56161679A JP16167981A JPS5862116A JP S5862116 A JPS5862116 A JP S5862116A JP 56161679 A JP56161679 A JP 56161679A JP 16167981 A JP16167981 A JP 16167981A JP S5862116 A JPS5862116 A JP S5862116A
Authority
JP
Japan
Prior art keywords
substance
hepatic
resultant
dialyzed
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56161679A
Other languages
Japanese (ja)
Other versions
JPH0148886B2 (en
Inventor
Naomi Takahashi
高橋 直躬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Priority to JP56161679A priority Critical patent/JPS5862116A/en
Publication of JPS5862116A publication Critical patent/JPS5862116A/en
Publication of JPH0148886B2 publication Critical patent/JPH0148886B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:The titled substance, obtained by treating an intestinal mucous membrane of a warm-blooded vertebrate with a salt solution containing no calcium, centrifugung the resultant homogenate, and dialyzing the resultant supernatant liquid, and useful as a hepatic functin promotor, etc. CONSTITUTION:The intestinal mucous membrane of a warm-blooded vertebrate, e.g. a rat, mouse or domestic fowl, is collected, and treated with a salt solution, e.g. Tyrode's solution, containing substantially no calcium to give a homogenate, which is then centrifuged. The resultant supernatant liquid after the centrifugation is heated at 60-100 deg.C and dialyzed to afford the aimed substance. The resultant substance is nondialytic and eluted by the chromatography with ''ConA- Sepharose '' without exhibiting the property of polysaccharide or glycoprotein. The compound has multiplication promoting action on the hepatic cell, and the hepatic parenchymal cell can be cultivated by adding the substance even to a culture medium containing no blood serum. The substance is expected to be applied as a hepatic function promotor, etc.

Description

【発明の詳細な説明】 本発F!Aは肝細胞の増殖促進物質に関する。[Detailed description of the invention] Original F! A relates to a hepatocyte growth promoting substance.

本発明者は、温血動物の腸粘膜よシ、肝細、胞の増殖を
促進する物質を得るべく種々検討した結果、本発明に到
達した。すなわち、本発明の畳旨は、温血せきつい動物
の腸粘膜を採取し。
The present inventor has arrived at the present invention as a result of various studies aimed at obtaining a substance that promotes the proliferation of intestinal mucosa, liver cells, and cells in warm-blooded animals. That is, the method of the present invention is to collect intestinal mucosa from warm-blooded animals.

これをカルシウムを実質的に含有しない塩1Illii
治液で処理してホモジネートを得、次いで仁の上清を加
熱し、更に透析することによ)取得される物質であって
、非透析性であり、 OOn人−セファロースクv:1
マドグツフィーにより溶出され、かつ肝細胞の増殖促進
作用を有することを特徴とする肝細胞の増殖促進物質に
ある。
Add this to salt 1Illii which does not substantially contain calcium.
a non-dialyzable substance, obtained by treatment with a treatment solution to obtain a homogenate, followed by heating of the kernel supernatant and further dialysis);
The present invention is a hepatocyte proliferation-promoting substance, which is eluted by Madgutuffy and has a hepatocyte proliferation-promoting effect.

以下、本発明を詳細KifIi1する。The present invention will be described in detail below.

本発明における温血せきつい動物としては、ラット、マ
ウス、ニワトリ、ヤギ、ウシ、ウサギ、ブタ、ウマ勢が
挙げられる。
Warm-blooded animals in the present invention include rats, mice, chickens, goats, cows, rabbits, pigs, and horses.

これらの動物の腸粘膜の極類としては、小腸、Tw&、
−二Jll膓、空腸、廻腸、大腸が挙げられるが%通常
、ウシ、ブタ、ニワトリ等の/h腸、盲腸が好mK使用
される。
The polar types of intestinal mucosa of these animals include the small intestine, Tw&,
Examples include the intestine, jejunum, stent, and large intestine, but usually, the intestine and cecum of cows, pigs, and chickens are preferably used.

本発BAK係る促進物質は、たとえば次のような方法に
よって得られゐ。
The BAK-promoting substance of the present invention can be obtained, for example, by the following method.

まず、上記動物の腸粘膜を採取する。採取は、通常、擦
過法により、腸上皮粘膜組織を得る。
First, the intestinal mucosa of the above animal is collected. Intestinal epithelial mucosal tissue is usually collected by a scraping method.

これをカルシウムを1質的に含有しない塩類溶液で処理
してホモジネートを得る。ζわらの工程は通常O−−℃
程度の温度で行なわれる。2上記塩類溶液としては、た
とえばタイロード溶液(Tyrode’g 5olut
ion )  (以下、「OM F J。
This is treated with a saline solution that is qualitatively free of calcium to obtain a homogenate. ζStraw process is usually O--℃
It is carried out at a certain temperature. 2 Examples of the above salt solution include Tyrode's solution (Tyrode's solution).
ion) (hereinafter referred to as “OMFJ.

という)が使用される。この溶液の組成は次のとおりで
ある。
) is used. The composition of this solution is as follows.

Ha□tr、00     Ha、HPO4/、/jK
OJ!   o、、zo     in、po、   
o、、2゜(g/l) すなわち、塩?Ili溶液としてけに+Na %にXを
含有するものが好適である。
Ha□tr, 00 Ha, HPO4/, /jK
OJ! o,,zo in,po,
o,,2゜(g/l) In other words, salt? As the Ili solution, one containing X in Na+Na% is suitable.

カルシウムがi!まれる#1液を使用すると1本発明の
所期の目的を達することができない、さらKYグネシウ
ムをも実質的に含有しない塩類fIIr液が最も好まし
い。すなわちカルシウム及び實グネシウムを含有しない
ものが最適である。
Calcium is i! If the #1 liquid contained in the present invention is used, the intended purpose of the present invention cannot be achieved, and a salt flIr liquid which does not substantially contain KY magnesium is most preferred. In other words, it is best to use one that does not contain calcium or magnesium.

次いでホモジネートから、遠心分離等によシ上清を得ゐ
、遠心分離によるときけ、通常100ρ〜/コ、ooo
xtで数分以上で行なわれるO得られた上清は加熱され
、変性した高分子タンパクは沈殿除去される。加熱は6
0〜100℃sF!Lで行なわれる0次いで上清を上記
塩類溶液、たとえばGMFで透析処理し、低分子量成分
が除去される。
Next, a supernatant is obtained from the homogenate by centrifugation, etc., and when centrifuged, the supernatant is usually 100 ρ~/co, ooo
The supernatant obtained is heated to precipitate and remove denatured high molecular weight proteins. Heating is 6
0~100℃sF! The supernatant is then dialyzed against the above saline solution, such as GMF, to remove low molecular weight components.

このようにして取得され石物質は、次のような性質を有
する。
The stone material thus obtained has the following properties.

イ)良好な熱安定性を示し、非透析裡である。b) Shows good thermal stability and is non-dialyzed.

o)  Oonム(コンカナバリンA)−セファロース
クラットゲラフィーにより溶出される。
o) Concanavalin A - eluted by Sepharose gelatinography.

すなわち、多軸類又は糖タンパク質の性状を示さない。That is, it does not exhibit properties of polyaxes or glycoproteins.

ノ、)BD8ボリアクリルアきドゲルによる電気泳動図
は分子量約4t/、000〜/l、000KJ本のバン
ドを有する。
2) The electropherogram obtained from the BD8 polyacrylic acid gel has a band with a molecular weight of about 4t/,000-/l, 000KJ.

→ 動物によるI[QIA性を示さない・ホ)肝細胞の
増殖促進作用を有し、血清無溢加培地でもこの物質を添
加することkよって肝実質細胞の培養が可能である。
→ It has the effect of promoting the growth of hepatocytes in animals (does not exhibit QIA properties), and by adding this substance, it is possible to culture hepatic parenchymal cells even in a serum-free medium.

以上のように、本発明に係る物質は、肝機能促進剤勢と
しての適用が期待される。
As described above, the substance according to the present invention is expected to be applied as a liver function promoter.

以下、本発明を実施例岐より、さらに詳細に説明するが
、本発明はその要旨を超えないかぎり、これら実施例に
限定されるものではない。
Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples unless it exceeds the gist thereof.

実施例/ 加し、その増殖をみ九〇 (1)小腸粘膜の採取及び抽出法 ラットを軽くエーテル麻酔し、頚動脈を切断、放血後、
開腹して全小腸をとシだし、小腸内容物をしぼシ出し、
冷OMF溶液で洗浄し、た。これを手術用ハサiで縦忙
切り開き。
Example/ In addition, to observe its proliferation, 90 (1) Collection and extraction method of small intestine mucosa A rat was lightly anesthetized with ether, the carotid artery was cut, and after exsanguination,
Open the abdomen, remove the entire small intestine, squeeze out the contents of the small intestine,
Washed with cold OMF solution. Cut this open vertically with surgical scissors.

ビンセットで小腸粘膜を擦過採取し、約/θ倍容のOM
F溶液でホモジネート後、 i−、oo。
Scrape the small intestine mucosa with a bottle set and collect approximately /θ times the volume of OM.
After homogenization with F solution, i-,oo.

XW、30分間遠心分離し、上清を小腸粘膜抽出物とし
た・ (2)加熱および透析処理 得られた小腸粘膜抽出物を% 100℃、−分間加熱後
、i2.oooxt、ao分関連心分離し上清を、’O
MF溶液で、2y時間透析した・(3(試験 基本培地としてl[fagl・MEM(組成を表1K示
す)を使用して、再生肝手術(注l)又は再生肝II!
似手術(注−)をし九ラット(術後−24を時間後)の
加熱、透析[、た小腸粘膜抽出物(/、j W pro
tein / 7 )を/Q%添加E。
XW, centrifuged for 30 minutes, and the supernatant was used as a small intestine mucosal extract. (2) Heating and dialysis treatment The obtained small intestine mucosal extract was heated at 100°C for - minutes, and then heated i2. oooxt, ao min-related heart isolation and supernatant, 'O
Dialyzed with MF solution for 2y hours, Regenerative Liver Surgery (Note 1) or Regenerative Liver II!
Small intestinal mucosal extract (/, j W pro
tein/7)/Q% addition E.

九壷結果を表2に示す・ なお、新生児ラット肝細胞培養方法及び細胞数の測定方
法−け次のとお夛である。
The results are shown in Table 2.The method for culturing neonatal rat hepatocytes and the method for measuring the number of cells is as follows.

a)新生児ラット肝細胞培養方法 生後乙日目の新生児ラッ)/〜10w74を断電、放血
し、2θ%エタノールで消毒後、無菌箱の中に入t1%
以後遠心分離以外はすべて無抛箱中で操作した。腹部を
ハサiで切開し、全肝臓をとシだし、CMF溶液でよ〈
洗浄し、力ζソリの刃で約/H角の大きさに細切した。
a) Neonatal rat hepatocyte culture method Neonatal rats)/~10w74 were cut off from electricity, exsanguinated, and sterilized with 2θ% ethanol, then placed in a sterile box.
Thereafter, all operations except centrifugation were performed in a cage-free box. Make an incision in the abdomen with scissors, remove the whole liver, and clean it with CMF solution.
It was washed and cut into pieces of approximately /H square size using a force-ζ sled blade.

細切した肝臓を0.O7%コラ−ゲナーゼ(Haゎks
溶*に溶がしたもの、蚊溶液の組成は1表3に示す)で
32℃、1時間インキエベートし、その後二重のナイロ
ンガーゼでろ過し、oMy溶液で洗浄後、再度二1のナ
イロンガーゼで□ろ過した。ろ過した粗細胞浮遊液をダ
θ×t、−分間低速遠心分離し、肝実質細胞を集め、そ
の上清を取り除き、ふたたびOMν溶液を加え、軽くピ
ペッティングし、同様に遠心分離し、以下同じ遠心操作
を一回〈り返し、細胞をよく洗浄した。
Shredded liver at 0. O7% collagenase (Hawaks)
The composition of the mosquito solution is shown in Table 1) and incubate for 1 hour at 32°C, then filtered through double nylon gauze, washed with oMy solution, and filtered again through 21 nylon gauze. It was filtered with □. The filtered crude cell suspension was centrifuged at low speed for dθ x t, - minutes to collect hepatic parenchymal cells, the supernatant was removed, OMν solution was added again, pipetted gently, centrifuged in the same way, and the same The centrifugation operation was repeated once to thoroughly wash the cells.

洗浄した細胞を目的とする培地にいれ、シラスチックシ
ャーレ(3jX/jlIJI)K各/、jCCずつ細胞
をまき、32℃、2J96air −j X00. ノ
気相テ培養t−*。
The washed cells were placed in the target medium, and the cells were sown in Silastic Petri dishes (3jX/jlIJI) K/jCC each, and incubated at 32°C, 2J96air-jX00. Gas phase culture t-*.

b)細胞数の測定方法 培養後、測定日にシャーレtとり出し。b) Method for measuring cell number After culturing, remove the petri dish on the day of measurement.

培地を取り除き0.−2j%トリプシン(CMνflI
箪に溶かしたもの)で37℃、30分間インキエベート
し細胞をシャーレよりはがした。その細胞浮遊液を10
0Xf、10分関連心分離し、細胞を集めそれを既知友
のCM1溶液KMIかし、トリノくンプルーで染色後、
肝実質の生細胞のみを、ヘマトメータにより測定した(
トリバンプルーの染色により、核の染まらないものを生
細胞とした)。なお、各3個のシャーレを測定し、その
平均値を細胞数とした。
Remove the medium and 0. −2j% trypsin (CMνflI
The cells were incubated for 30 minutes at 37° C. and then peeled off from the petri dish. 10% of the cell suspension
0Xf for 10 min, isolated the relevant hearts, collected the cells, and stained them with a well-known CM1 solution, KMI, and Turin Blue.
Only living cells in the liver parenchyma were measured using a hematometer (
Cells with no nuclear staining were considered viable cells by Trivan blue staining). Note that measurements were taken for each of three Petri dishes, and the average value was taken as the cell number.

注り 再生肝手術方法 ラット肝臓の再生肝手術は、肝の鉛を 切除する。 Hlgginll &ムnderson 
の方法を用いた。すなわち、動物を軽くエーテル麻酔し
、固定台に仰臥位に固定後1手術野を刷毛、70%エタ
ノールで消毒し、白線上を剣状突起まで、Jm(5切開
し、その仏前胸部を指で圧迫し、中葉、左葉な露出させ
、その露出肝葉の裏面よシ縫合糸をかけ、厳重に集中結
紮し、肝葉を切除した。切除ビンで消毒した(なお手術
は常に午前10時半から/一時の間におこなった・)・
注−2)再生肝擬似手術方法 再生肝手術と同様に腹部を切開し、肝葉を5分間はど腹
腔外Kjl出した後、2θ%エタノールで消毒し、腋腔
内にもどした。
Note Regenerative liver surgery method Rat liver regenerative liver surgery involves removing lead in the liver. Hlgginll & Munderson
The method was used. That is, after the animal was lightly anesthetized with ether and fixed in the supine position on a fixation table, the surgical field was disinfected with a brush and 70% ethanol, Jm (5 incisions were made on the linea alba up to the xiphoid process, and the anterior thorax was made with a finger. The middle lobe and left lobe were exposed by applying pressure, sutures were placed on the back side of the exposed liver lobe, the liver lobe was tightly ligated, and the liver lobe was excised.It was sterilized with a resection bottle (surgery was always performed at 10:30 a.m. From / It took place for an hour.)
Note-2) Regenerative liver sham surgery method: The abdomen was incised in the same manner as in regenerative liver surgery, and the liver lobe was extracted outside the peritoneal cavity for 5 minutes, disinfected with 2θ% ethanol, and returned into the axillary cavity.

以下は、再生肝手術と同様に縫合、消毒した。The following parts were sutured and disinfected in the same way as in regenerative liver surgery.

表−新生児ラット肝細胞の細MI数 (ml)擬似手術をしたラットの加熱透析した小腸粘膜
抽出物添加(10%) (**)再生肝手術をしたラットの加熱透析した小腸粘
膜抽出物添加(io%) すなわち、上記小腸粘膜抽出物の添加によ〕、新生児ラ
ットの培養肝細胞の**な増殖がみられる。
Table - Micro MI number of neonatal rat hepatocytes (ml) Addition of heat-dialyzed small intestine mucosal extract from rats that underwent sham surgery (10%) (**) Addition of heat-dialyzed small intestine mucosa extract from rats that underwent regenerative liver surgery (io%) That is, with the addition of the above-mentioned small intestine mucosal extract, **proliferation of cultured hepatocytes of neonatal rats was observed.

嵌J   Hanks溶液の組成 pH7,44 *施例コ 小腸粘膜抽出物を成熟ラットの肝細胞培養に添加し、細
胞の接着率、増殖、肝模能をみた(基本培地: lag
le MIM a ) e培IIIIK供試する動物は
、生後約−ケ月の8prauge −nawxey糸雄
ラットを使用した。
Composition of J Hanks solution pH 7,44 *Example Small intestine mucosal extract was added to hepatocyte culture of adult rats, and cell adhesion rate, proliferation, and liver function were observed (basic medium: lag
The animals to be tested were 8-month-old 8-month-old male rats.

a)細胞数の測定 細胞数の測定は、実九例/と同様の方法で行なった。正
常なラットの加熱透析した小腸粘膜抽出物(0,3W 
prots+tn 7wt )を7θ%添加し、正常ラ
ット血清を70%添加した場合と比較した。結果を表4
tK示す。
a) Measurement of cell number Cell number was measured in the same manner as in Example 9. Heat-dialyzed small intestine mucosal extract of normal rats (0.3W
prots+tn 7wt) was added at 7θ% and compared with the case where normal rat serum was added at 70%. Table 4 shows the results.
tK is shown.

表ダ 成熟ラット肝細胞の細胞数 (x10@) (*3)正常ラット血清添加(70%)(*4)正常ラ
ットの加熱透析した小腸粘膜抽出物添加(10’X) 上記小腸粘膜抽出物を添加した培地で は、7日間はぼ細胞数を維持するが、正常なラット血清
を添加した培地でけ徐々に減少することがわかる。
Table D Number of adult rat hepatocytes (x10@) (*3) Addition of normal rat serum (70%) (*4) Addition of heat-dialyzed small intestine mucosal extract of normal rat (10'X) Above small intestine mucosa extract It can be seen that the number of rat cells is maintained for 7 days in the medium supplemented with 100% rat serum, but gradually decreases in the medium supplemented with normal rat serum.

b)細胞の接着率 正常なラットの加熱透析した小腸粘膜抽出物θ、t w
g protein / mlを10%添加したものと
0.J Mf prot・1m7@lを7θ%添加した
ものを使用した。対照として、正常ラット血清をioX
添加し九本のと、無添加のものを使用した。結果を表!
に示す− なお、細胞数の接着率の測定方法は次のとおりである。
b) Cell adhesion rate Heat-dialyzed small intestinal mucosal extract of normal rats θ, t w
10% g protein/ml and 0.0 g protein/ml. JMf prot・1m7@l was added at 7θ%. As a control, normal rat serum was ioX
Nine additives and one without additives were used. Show your results!
The method for measuring the adhesion rate of cell numbers is as follows.

すなわち、培養−ダ時間vkKシャーレを取着出し、培
地を取り除きOM?溶液で洗浄後、θ、コI%トリズシ
ンで32℃、Jθ分間インキエベートシ、細胞をけがし
、トリバンブルーにて細胞数を測定した・最初Km胞を
まいた数に対するシャーレの底に付着した細胞の百分率
で示した。
That is, take out the culture dish, remove the culture medium, and remove the culture medium. After washing with the solution, the cells were incubated with θ, COI% Trizucin at 32°C for Jθ minutes, the cells were scratched, and the number of cells was measured with Trivan blue. Percentage of cells attached to the bottom of the petri dish relative to the number of initially seeded Km cells. It was shown in

表!接着率 ム: 0.J W protein/sl/B : 0
.11lvprotllln/dすなわち、上記小腸粘
膜?Il出IfMをl=加【。
table! Adhesion rate: 0. JW protein/sl/B: 0
.. 11lvprotllln/d, that is, the above-mentioned small intestine mucosa? Add Il output IfM to l=[.

た場合KFi、有意に接動率が高まった。In the case of KFi, the engagement rate increased significantly.

C)培地中のアtノ鍼尿木、アンモニアの−j足 正雷ラットの加熱透析した小編粘に振出−に1096含
むEagle MEM 培z ? J f3 i1培養
した後、その培地をCMF浴、 lcagl・MKMの
各培地に551111L、!、6.fh閣。
C) Eagle MEM culture medium containing 1096 ml of ammonia in the culture medium, which was extracted from heat-dialyzed small viscosity of rats. After culturing J f3 i1, the culture medium was placed in a CMF bath, and 551111L of each medium of lcagl and MKM. ,6. fh cabinet.

32℃で1@貧し、各培地中のアミノ絵、尿jk、アン
モニアを1足した。&、果01Kn・す・ 法による。
The mixture was incubated at 32°C, and the amino acid, urine jk, and ammonia in each medium were added. &、According to the law.

−)尿素態輩素: ジアセチルモノオキシム法を用いた
測定試薬による。
-) Urea-form chloride: Based on a measurement reagent using the diacetyl monooxime method.

1it)  アンモニア態窒素: パーセロット(Be
rthslot )反応を用いた。
1it) Ammonia nitrogen: Parcelot (Be
rthslot) reaction was used.

表6  培地中の尿素、アンモニア、アミノ酸の変化(
尿素) (7ンモニ7) (agN/IIvcellular protein)
(アき)酸) 十なわち、上記小腸粘膜抽出物を添加し培養したときの
肝細胞の、St素代mにおける肝機能は、Ml!IMと
OMF溶液の≠なる培地条件によシ、アミノ酸、尿素、
アンモニアの生成が変化することから、充分な肝4!1
!能を保持していると思われる。
Table 6 Changes in urea, ammonia, and amino acids in the medium (
urea) (7mmoni7) (agN/IIvcellular protein)
(acid) acid) 10 That is, the liver function of hepatocytes at St prime age m when the above-mentioned small intestine mucosal extract was added and cultured was Ml! Depending on the medium conditions of IM and OMF solutions, amino acids, urea,
Because the production of ammonia changes, sufficient liver 4!1
! It seems that he has retained his abilities.

実施例3 ヤギ、ウサギ、ニワトリの加熱透析した小編粘膜抽出物
を培地に添加し、ラット肝細胞について、接着率、#I
殖をみた。
Example 3 Heat-dialyzed micromucosal extracts of goats, rabbits, and chickens were added to the culture medium, and adhesion rate, #I was determined for rat hepatocytes.
I saw the breeding.

ヤギは約3才の雌のザーネン棟、ウサギは約7θケ月齢
の雄のニューシーラントホワイト。
The goat is a female Saanen wing that is about 3 years old, and the rabbit is a New Sealant White male that is about 7 theta months old.

ニワトリは約−ヶ月齢の雄の白色レグホーンを使用した
The chickens used were male white Leghorn chickens approximately -month old.

a)  成熟ラット肝細胞の接着率 ヤギ、ウサギ、ニワトリの加熱透析した小腸粘膜抽出物
を、実施例/に記載された方法で得、これを10%添加
して行なった(θ、/ sy protein / 7
 )。このときの成熟ラット肝細胞の培養λダ時後の接
着率を表7に示す。
a) Adhesion rate of adult rat hepatocytes Heat-dialyzed small intestine mucosal extracts of goats, rabbits, and chickens were obtained by the method described in Examples, and this was carried out by adding 10% (θ, /sy protein /7
). Table 7 shows the adhesion rate of the mature rat hepatocytes after culture for λ days.

表7 接 着 率 b)新生児ラット肝細胞の細胞数 ヤギ、つヤギ、ニワトリの加熱透析した・  小腸粘膜
抽出物(θ、* 19 protein / d )を
70%添加した。結果を表♂に示す。
Table 7 Adhesion rate b) Number of neonatal rat hepatocytes 70% heat-dialyzed small intestinal mucosal extracts (θ, *19 protein/d) of goats, goats, and chickens were added. The results are shown in Table ♂.

実施例ダ a)  加熱透析した正常ラット不腸粘膜抽出物t O
onム−セファp−スクロマトグ2フィーによ)精製[
、た、すなわち0.1 M −MILOJ!−10mM
 Trim−110zバツフ7− pH7jで、平衡に
したのち、上記抽出物を添加[、。
Example a) Heat-dialyzed normal rat intestine mucosal extract tO
on Mu-Sefa p-chromatography) purification [
, i.e. 0.1 M-MILOJ! -10mM
After equilibration with Trim-110z buffer 7-pH 7j, the above extract was added.

上記バッファーで/ 0−/hrの速さで溶出り、た、
溶出パターンを図/に示す、溶出された分1mFi一つ
であった。
Elute with the above buffer at a rate of /0-/hr,
The elution pattern is shown in the figure, and one mFi was eluted.

b)この溶出された分画をコロジオンバックにて濃縮し
、iff生児ラント肝細胞培養の培地に添加し、!日間
培養しその時の増殖を出物(0,0ダW/sf)添加を
表わす。
b) Concentrate this eluted fraction in a collodion bag, add it to the culture medium of iff newborn runt hepatocytes, and! The cells were cultured for one day, and the growth at that time represents the addition of the product (0.0 DaW/sf).

C)溶出さ六た小腸粘膜抽出物を、!、−%BDBボリ
アクリルア建ドゲルにて、pH7,41,0,41M 
)リスー酢酸バッファーにて泳動した・染色はりマシー
ブルーにて染色した。その電気泳動図は、分子量約at
、oo。
C) Eluted small intestinal mucosa extract! , -%BDB polyacrylic acid gel, pH 7,41,0,41M
) Electrophoresis was carried out in Lys-acetic acid buffer. Staining was carried out using Massie blue. Its electropherogram shows a molecular weight of approximately at
,oo.

/4,00OK 7本のバンドを有するものであった。/4,00OK It had 7 bands.

実施例! 加熱透析した正常ラット小腸粘膜抽出物をシエファデツ
クスクロマトグラフィーにより分−し、フラクションコ
レクターに得られた分画物を、Jlonm ″l’UV
吸収スペクトルを測定した。結果を図3に示す。
Example! A heat-dialyzed normal rat small intestine mucosal extract was separated by Siefadex chromatography, and the obtained fraction was collected using a fraction collector.
Absorption spectra were measured. The results are shown in Figure 3.

【図面の簡単な説明】[Brief explanation of the drawing]

図’ ハ、COnム−セファロ−スフOW )グラフィ
ーによる正常ラットの加熱透析した小腸&’膜抽出物の
溶出区分を示し1図−F!溶出区分を添加したときの新
生児ラット肝mpiiの増殖をh−す図であり、図Jは
シエファデツクスクロマトグラフイーによる分画物のU
V吸収スペクトルを示す。 出 願 人  三菱化成工業株式会社 代 理 人  弁理士 要否用  − (はが7名) ■面の浄a(内容に友になレラ (¥II TubeHmber 手続補正口(放) 1 事件の表示 昭和56年特許願第161679号 2 発明の名称 肝細胞の増殖促進物質 3 補正をする者 事件との関係  出願人 (596)  三菱化成工業株式会社 4 代、埋 人 〒100 東京都千代田区丸の内二丁目5番2号 三菱化成工業株式会社内 5 補正命令の日付 昭和57年2月23日(発送日)
6 補正の対象   願書、明細書および図面7 補正
の内容
Figure 1-F shows the elution fraction of the heat-dialyzed small intestine and membrane extract of a normal rat by CONMU-CEPHOLOGY. Figure J shows the proliferation of neonatal rat liver mpii when the elution fraction is added;
The V absorption spectrum is shown. Applicant Mitsubishi Chemical Industries, Ltd. Agent Patent attorney Necessity - (7 people) ■ Mask of a (contents are not clear) 1956 Patent Application No. 161679 2 Name of the invention: Substance promoting proliferation of hepatocytes 3 Relationship to the case of the person making the amendment Applicant (596) 4th generation of Mitsubishi Chemical Industries, Ltd., Buried 2-chome Marunouchi, Chiyoda-ku, Tokyo 100 No. 5 No. 2 Mitsubishi Chemical Industries, Ltd. 5 Date of amendment order February 23, 1982 (shipment date)
6 Subject of amendment Application, specification, and drawings 7 Contents of amendment

Claims (1)

【特許請求の範囲】[Claims] (1)瀉血せきつい動物の腸粘膜を採取し、これをカル
シウムを実質的に含有しない塩類溶液で処理してホそジ
ネートを得、次いでこの上清を加熱し、更に透析すると
とKよシ取得される物質であって、非透析性であシ、 
OOnムーセファロースクロマトグラフイーによシ溶出
され、かつ肝細胞の増殖促進作用を有すること全特徴と
する肝細胞の増殖促進物質。
(1) Collect the intestinal mucosa of a bloodletting animal, treat it with a saline solution that does not substantially contain calcium to obtain hosogenate, then heat the supernatant and further dialyze to obtain K. a non-dialyzable substance;
A hepatocyte proliferation-promoting substance, which is eluted by OOn Mucepharose chromatography and has a hepatocyte proliferation-promoting effect.
JP56161679A 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell Granted JPS5862116A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56161679A JPS5862116A (en) 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56161679A JPS5862116A (en) 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell

Publications (2)

Publication Number Publication Date
JPS5862116A true JPS5862116A (en) 1983-04-13
JPH0148886B2 JPH0148886B2 (en) 1989-10-20

Family

ID=15739776

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56161679A Granted JPS5862116A (en) 1981-10-09 1981-10-09 Multiplication promoting substance for hepatic cell

Country Status (1)

Country Link
JP (1) JPS5862116A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243019A (en) * 1984-05-17 1985-12-03 Mitsubishi Chem Ind Ltd Hepatic cell proliferation factor
US5547856A (en) * 1992-05-18 1996-08-20 Genentech, Inc. Hepatocyte growth factor variants
US5580963A (en) * 1992-05-18 1996-12-03 Genentech, Inc. Single-chain hepatocyte growth factor variants
US5879910A (en) * 1992-05-18 1999-03-09 Genetech, Inc. Hepatocyte growth factor protease domain variants

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60243019A (en) * 1984-05-17 1985-12-03 Mitsubishi Chem Ind Ltd Hepatic cell proliferation factor
JPH0533206B2 (en) * 1984-05-17 1993-05-19 Mitsubishi Chem Ind
US5547856A (en) * 1992-05-18 1996-08-20 Genentech, Inc. Hepatocyte growth factor variants
US5580963A (en) * 1992-05-18 1996-12-03 Genentech, Inc. Single-chain hepatocyte growth factor variants
US5879910A (en) * 1992-05-18 1999-03-09 Genetech, Inc. Hepatocyte growth factor protease domain variants

Also Published As

Publication number Publication date
JPH0148886B2 (en) 1989-10-20

Similar Documents

Publication Publication Date Title
CN103789381B (en) A kind of method of Isin glue collagen rapid extraction
US11884953B2 (en) Method for preparing protein peptide based on connective tissue and prepared protein peptide and use thereof
Cohen et al. Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180
NO317699B1 (en) Process for preparing a protein concentrate coagulable with thrombin and containing mostly fibrinogen, endogenous factor XIII and fibronectin.
Cowdell et al. Constitutional anemia (Fanconi’s syndrome) and leukemia in two brothers
Leoci Animal by-products (ABPs): origins, uses, and European regulations
Davidson et al. The nucleoprotein content of fibroblasts growing in vitro: 2. The effect of tissue extracts
US2162863A (en) Stable products shortening the bleeding period
Baker et al. Effect of the amino acids and dialyzable constituents of embryonic tissue juice on the growth of fibroblasts
CN105420325A (en) Placenta polypeptide preparation method
JPS5862116A (en) Multiplication promoting substance for hepatic cell
CN103789382A (en) Method for rapidly extracting fish collagen protein by using enzymolysis method
CN110407951B (en) Polysaccharide from natural sources and application of polysaccharide in preparation of cosmetics for promoting skin repair and improving skin elasticity
CN1333082C (en) Method for high efficiency extracting collagen by alkali swelling acid enzymolysis
CA2113143A1 (en) Extract and process for the preparation of this extract
CN109810936A (en) A kind of cell culture based additive
US5750378A (en) Method for preparing cellular fibronectin
CN109810187A (en) A kind of extracting method and application of animal tendon tendon collagen
Hartman Cortin, vital hormone of the adrenal cortex
JPS60243019A (en) Hepatic cell proliferation factor
CN110935003A (en) Biological polypeptide composition for promoting skin injury repair
CN110241074A (en) A kind of preparation method of Novel goat sperm in vitro agonist
Thompson The metabolism of arginine
JP2005312338A (en) Carrier for culturing cell
JPS60133886A (en) Preparation of components of cell growing culture medium